Literature DB >> 1425067

Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute cholecystitis.

R Orda1, S A Berger, Y Levy, A Shnaker, A Gorea.   

Abstract

The penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue was prospectively studied in 21 adult patients undergoing early surgery for acute cholecystitis. Comparable tissue, bile, and serum concentrations of the drugs were demonstrable; however, significantly fewer preoperative doses of ceftriaxone were required for adequate perioperative treatment. In view of its higher serum half-life and superior antibacterial activity toward common biliary pathogens, ceftriaxone appears to be a useful drug for the perioperative management of acute cholecystitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425067     DOI: 10.1007/bf01299860

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.

Authors:  S A Berger; Y Levy; A Halevy; A Gorea; R Orda
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

2.  Ceftriaxone: renal and biliary excretion and effect on the colon microflora.

Authors:  A Arvidsson; G Alván; B Angelin; O Borgå; C E Nord
Journal:  J Antimicrob Chemother       Date:  1982-09       Impact factor: 5.790

Review 3.  Hepatic bile flow.

Authors:  R C Strange
Journal:  Physiol Rev       Date:  1984-10       Impact factor: 37.312

Review 4.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

5.  Biliary excretion and pharmacokinetics of cefoperazone in humans.

Authors:  B Kemmerich; H Lode; K Borner; D Belmega; T Jendroschek; P Koeppe; G Goertz
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

6.  Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy.

Authors:  W L Hayton; R Schandlik; K Stoeckel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Biliary excretion of amoxycillin and ceftriaxone after intravenous administration in man.

Authors:  D P Maudgal; J D Maxwell; L J Lees; R N Wild
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

8.  Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.

Authors:  K R Ratzan; H B Baker; I Lauredo
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  Biliary excretion of cephalosporins in rats: influence of molecular weight.

Authors:  W E Wright; V D Line
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

10.  Cefoperazone concentrations in bile and gall bladder wall after intravenous administration.

Authors:  T Nakamura; I Hashimoto; Y Sawada; J Mikami; E Bekki; S Hirasawa; H Abe; Y Watanabe
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

  10 in total
  5 in total

Review 1.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Human Bile Reduces Antimicrobial Activity of Selected Antibiotics against Enterococcus faecalis and Escherichia coli In Vitro.

Authors:  Beatrix Wulkersdorfer; David Jaros; Sabine Eberl; Stefan Poschner; Walter Jäger; Enrico Cosentini; Markus Zeitlinger; Richard Schwameis
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.

Authors:  Atsushi Tanaka; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Masahiro Yoshida; Fumihiko Miura; Masahiko Hirota; Keita Wada; Toshihiko Mayumi; Harumi Gomi; Joseph S Solomkin; Steven M Strasberg; Henry A Pitt; Jacques Belghiti; Eduardo de Santibanes; Robert Padbury; Miin-Fu Chen; Giulio Belli; Chen-Guo Ker; Serafin C Hilvano; Sheung-Tat Fan; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

4.  Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines.

Authors:  Masahiro Yoshida; Tadahiro Takada; Yoshifumi Kawarada; Atsushi Tanaka; Yuji Nimura; Harumi Gomi; Masahiko Hirota; Fumihiko Miura; Keita Wada; Toshihiko Mayumi; Joseph S Solomkin; Steven Strasberg; Henry A Pitt; Jacques Belghiti; Eduardo de Santibanes; Sheung-Tat Fan; Miin-Fu Chen; Giulio Belli; Serafin C Hilvano; Sun-Whe Kim; Chen-Guo Ker
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

5.  Preoperative antimicrobial administration for prevention of postoperative infection in patients with laparoscopic cholecystectomy.

Authors:  Kazuhisa Uchiyama; Manabu Kawai; Hironobu Onishi; Masaji Tani; Hiroyuki Kinoshita; Masaki Ueno; Hiroki Yamaue
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.